- Home
- ACXP vs ORIS Comparison
ACXP vs ORIS Comparison
Compare ACXP & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- ORIS
- Stock Information
- Founded
- ACXP 2017
- ORIS 2014
- Country
- ACXP United States
- ORIS China
- Employees
- ACXP N/A
- ORIS N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- ORIS Farming/Seeds/Milling
- Sector
- ACXP Health Care
- ORIS Consumer Staples
- Exchange
- ACXP Nasdaq
- ORIS Nasdaq
- Market Cap
- ACXP 6.8M
- ORIS 5.3M
- IPO Year
- ACXP 2021
- ORIS 2024
- Fundamental
- Price
- ACXP $4.17
- ORIS $0.18
- Analyst Decision
- ACXP Strong Buy
- ORIS
- Analyst Count
- ACXP 3
- ORIS 0
- Target Price
- ACXP $143.67
- ORIS N/A
- AVG Volume (30 Days)
- ACXP 70.5K
- ORIS 15.9M
- Earning Date
- ACXP 11-12-2025
- ORIS 01-01-0001
- Dividend Yield
- ACXP N/A
- ORIS N/A
- EPS Growth
- ACXP N/A
- ORIS N/A
- EPS
- ACXP N/A
- ORIS 0.17
- Revenue
- ACXP N/A
- ORIS $15,014,000.00
- Revenue This Year
- ACXP N/A
- ORIS N/A
- Revenue Next Year
- ACXP N/A
- ORIS N/A
- P/E Ratio
- ACXP N/A
- ORIS $0.80
- Revenue Growth
- ACXP N/A
- ORIS N/A
- 52 Week Low
- ACXP $3.80
- ORIS $0.08
- 52 Week High
- ACXP $44.00
- ORIS $56.01
- Technical
- Relative Strength Index (RSI)
- ACXP 37.31
- ORIS 58.77
- Support Level
- ACXP $4.02
- ORIS $0.11
- Resistance Level
- ACXP $4.34
- ORIS $0.12
- Average True Range (ATR)
- ACXP 0.49
- ORIS 0.02
- MACD
- ACXP 0.10
- ORIS 0.02
- Stochastic Oscillator
- ACXP 10.24
- ORIS 78.64
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).